DR. JAMES MOND
Medical Practice at Gaither Rd, Gaithersburg, MD
License number
Maryland DOO23647
Category
Medical Practice
Type
Military Health Care Provider
Address
Address
2
9119 Gaither Rd, Gaithersburg, MD 20877
527 Northwest Dr NORTHWEST, Silver Spring, MD 20901
527 Northwest Dr NORTHWEST, Silver Spring, MD 20901
Phone
(301) 987-1160
(301) 330-5868 (Fax)
(301) 330-5868 (Fax)
Personal information
See more information about JAMES MOND at radaris.comName
Address
Phone
11804 Greenleaf Ave, Potomac, MD 20854
527 Northwest Dr, Silver Spring, MD 20901
Silver Spring, MD
527 Northwest Ter, Silver Spring, MD 20901
Organization information
See more information about JAMES MOND at bizstanding.comJames Mond MD,PHD
9119 Gaither Rd, Gaithersburg, MD 20877
Industry:
Allergist, Internist
Phone:
(301) 987-1160 (Phone)
James Jacob Mond
Professional information
Dr. James J Mond, Gaithersburg MD - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
9119 Gaither Rd, Gaithersburg 20877
(301) 987-1160 (Phone), (301) 330-5868 (Fax)
(301) 987-1160 (Phone), (301) 330-5868 (Fax)
Certifications:
Internal Medicine, 1976, Rheumatology, 1980
Languages:
English
Education:
Medical School
New York University School Of Medicine
Graduated: 1973
Mount Sinai Hospital
New York University School Of Medicine
Graduated: 1973
Mount Sinai Hospital
Background:
Board Actions: 2 time(s)
Compositions Comprising Lysostaphin Variants And Methods Of Using The Same
US Patent:
2008009, Apr 24, 2008
Filed:
Sep 5, 2007
Appl. No.:
11/850150
Inventors:
Jeffrey Stinson - Brookeville MD, US
Luba Grinberg - Gaithersburg MD, US
James Mond - Silver Spring MD, US
Luba Grinberg - Gaithersburg MD, US
James Mond - Silver Spring MD, US
Assignee:
Biosynexus Incorporated - Gaithersburg MD
International Classification:
A61K 38/48, A61P 31/04, C12N 9/52
US Classification:
424094630, 435220000
Abstract:
The present invention relates to compositions comprising lysostaphin variants and methods of using the same. In particular, the present invention provides de-immunized lysostaphin variants and methods of using the same (e.g., to treat microbial infection in or on a subject).
Methods And Formulations For Eradicating Or Alleviating Staphylococcal Nasal Colonization Using Lysostaphin
US Patent:
2003021, Nov 13, 2003
Filed:
Dec 20, 2002
Appl. No.:
10/323907
Inventors:
Scott Walsh - Germantown MD, US
James Mond - Silver Spring MD, US
Tatyana Chanturiya - Rockville MD, US
James Mond - Silver Spring MD, US
Tatyana Chanturiya - Rockville MD, US
International Classification:
A61K038/17
US Classification:
514/012000
Abstract:
This invention provides lysostaphin intranasal compositions that can be administered to the anterior nares of those at risk for staphylococcal nasal colonization and subsequent infection and methods for their use.
Antimicrobial Polymer Conjugate Containing Lysostaphin And Polyethylene Glycol
US Patent:
7452533, Nov 18, 2008
Filed:
Mar 26, 2003
Appl. No.:
10/403223
Inventors:
Scott M. Walsh - Germantown MD, US
Anjali G. Shah - North Potomac MD, US
James J. Mond - Silver Spring MD, US
Andrew Lees - Silver Spring MD, US
Joseph J. Drabick - Silver Spring MD, US
Anjali G. Shah - North Potomac MD, US
James J. Mond - Silver Spring MD, US
Andrew Lees - Silver Spring MD, US
Joseph J. Drabick - Silver Spring MD, US
Assignee:
Biosynexus Incorporated - Gaithersburg MD
International Classification:
A61K 38/48, A61K 38/51, C12N 11/08
US Classification:
424 9463, 435180
Abstract:
Water-soluble polymer conjugates of antimicrobial agents retaining at least a portion of the antimicrobial activity of the agent, pharmaceutical compositions containing the polymer conjugates, and methods for treating microbial infections with the pharmaceutical compositions.
Methods For Blocking Or Alleviating Staphylococcal Nasal Colonization By Intranasal Application Of Monoclonal Antibodies
US Patent:
2003022, Dec 4, 2003
Filed:
Dec 20, 2002
Appl. No.:
10/323904
Inventors:
Jeffrey Stinson - Brookville MD, US
Scott Walsh - Germantown MD, US
Andrew Lees - Silver Spring MD, US
James Mond - Silver Spring MD, US
Gerald Fischer - Bethesda MD, US
Scott Walsh - Germantown MD, US
Andrew Lees - Silver Spring MD, US
James Mond - Silver Spring MD, US
Gerald Fischer - Bethesda MD, US
International Classification:
A61K039/40, A61K038/16
US Classification:
424/165100, 514/002000
Abstract:
This invention provides MAbs for blocking and alleviating nasal colonization by staphylococci and methods for their use in the anterior nares.
Enzyme Disruption Of Bacterial Biofilms
US Patent:
7572439, Aug 11, 2009
Filed:
Mar 26, 2003
Appl. No.:
10/401342
Inventors:
Julie M. Adams - Columbia MD, US
James J. Mond - Silver Spring MD, US
Scott M. Walsh - Germantown MD, US
Anjali G. Shah - North Potomac MD, US
Tanya I. Chanturiya - Gaithersburg MD, US
James J. Mond - Silver Spring MD, US
Scott M. Walsh - Germantown MD, US
Anjali G. Shah - North Potomac MD, US
Tanya I. Chanturiya - Gaithersburg MD, US
Assignee:
Biosynexus Incorporated - Gaithersburg MD
International Classification:
A61K 38/46
US Classification:
424 946
Abstract:
Methods for treating patients in which damaged tissue or an indwelling prosthetic device or catheter has a bacterial biofilm growing thereon, to at least partially disrupt said biofilm, by administering at least one antibacterial enzyme that is lethal or damaging to the biofilm-forming bacteria in an amount that is effective to at least partially disrupt the biofilm upon contact therewith. Methods for prophylactically treating a patient, and methods for disinfecting or sterilizing a surface ex-vivo to remove a biofilm or prevent biofilm growth are also disclosed, as well as implantable articles susceptible to biofilm growth to which a prophylactic coating of an antibacterial enzyme has been applied.
Compositions And Methods For Treating Bacteria
US Patent:
7576054, Aug 18, 2009
Filed:
Oct 11, 2006
Appl. No.:
11/545884
Inventors:
Scott Michael Walsh - Poughquag NY, US
Mary Catherine Pittaway - Poughquag NY, US
James J. Mond - Silver Spring MD, US
Mary Catherine Pittaway - Poughquag NY, US
James J. Mond - Silver Spring MD, US
Assignee:
Biosynexus Incorporated - Gaithersburg MD
International Classification:
A61K 38/14, A61K 39/02
US Classification:
514 2, 514 12, 424445
Abstract:
The present invention relates to the field of bacteriology. In particular, the present invention provides compositions (e. g. , comprising a lantibiotic and mupirocin or gentamicin) and methods of treating (e. g. , killing or inhibiting growth of) bacteria. For example, the present invention provides pharmaceutical compositions (e. g. , comprising a lantibiotic and mupirocin or gentamicin) and methods of using the same in research, therapeutic and drug screening applications.
Antigenic Polypeptides
US Patent:
7410647, Aug 12, 2008
Filed:
Aug 2, 2002
Appl. No.:
10/485517
Inventors:
Simon Foster - Hathersage, GB
James Mond - Silver Spring MD, US
Simon Clarke - Sheffield, GB
Philip McDowell - Middlesex, GB
Kristy Brummel - Sheffield, GB
James Mond - Silver Spring MD, US
Simon Clarke - Sheffield, GB
Philip McDowell - Middlesex, GB
Kristy Brummel - Sheffield, GB
Assignee:
University of Sheffield - Sheffield
Biosynexus Incorporated - Gaithersburg MD
Biosynexus Incorporated - Gaithersburg MD
International Classification:
A61K 39/085, A61K 39/00, C12P 21/04, C07H 21/04, C07K 14/00
US Classification:
4242431, 4242341, 4241841, 530350, 530300, 536 237, 4353201, 4352521, 435199, 435 697
Abstract:
A method for the identification of antigenic polypeptides, typically opsonic antigens, expressed by pathogenic microbes; vaccines comprising said antigens; and therapeutic antibodies directed to said antigenic polypeptides.
Antimicrobial Polymer Conjugates
US Patent:
2009008, Mar 26, 2009
Filed:
Nov 14, 2008
Appl. No.:
12/271654
Inventors:
Scott M. Walsh - Germantown MD, US
Anjali G. Shah - North Potomac MD, US
James J. Mond - Silver Spring MD, US
Andrew Lees - Silver Spring MD, US
Joseph J. Drabick - Silver Spring MD, US
Anjali G. Shah - North Potomac MD, US
James J. Mond - Silver Spring MD, US
Andrew Lees - Silver Spring MD, US
Joseph J. Drabick - Silver Spring MD, US
Assignee:
BIOSYNEXUS, INCORPORATED - Gaithersburg MD
International Classification:
A61K 38/48, C12N 9/52
US Classification:
424 943, 435188
Abstract:
Water-soluble polymer conjugates of antimicrobial agents retaining at least a portion of the antimicrobial activity of the agent, pharmaceutical compositions containing the polymer conjugates, and methods for treating microbial infections with the pharmaceutical compositions.
Antigenic Polypeptides
US Patent:
2009026, Oct 29, 2009
Filed:
Aug 11, 2008
Appl. No.:
12/189576
Inventors:
Simon Foster - Hathersage, GB
James Mond - Silver Spring MD, US
Simon Clarke - Sheffield, GB
Philip McDowell - Middlesex, GB
Kirsty Brummel - Sheffield, GB
James Mond - Silver Spring MD, US
Simon Clarke - Sheffield, GB
Philip McDowell - Middlesex, GB
Kirsty Brummel - Sheffield, GB
Assignee:
UNIVERSITY OF SHEFFIELD - Sheffield
BIOSYNEXUS CORPORATION - Gaithersburg MD
BIOSYNEXUS CORPORATION - Gaithersburg MD
International Classification:
A61K 39/395, C07K 14/00, A61K 38/16, A61P 37/04, C07K 16/00
US Classification:
4241391, 530350, 514 12, 5303879, 5303873
Abstract:
The invention relates to a method for the identification of antigenic polypeptides, typically opsonic antigens, expressed by pathogenic microbes; vaccines comprising said antigens; and therapeutic antibodies directed to said antigenic polypeptides.